LENSAR, INC. Investing Cash Flow
LENSAR, INC. (LNSR) reported Investing Cash Flow of $4.96 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivities · last filed 2026-08-13
- LENSAR, INC. net cash provided by (used in) investing activities for the quarter ending 2026-06-30 was $965.00K.
- LENSAR, INC. net cash provided by (used in) investing activities for the quarter ending 2026-03-31 was $4.00M, a 653.30% increase year-over-year.
- LENSAR, INC. net cash provided by (used in) investing activities for the quarter ending 2025-12-31 was $4.25M, a 113.10% increase year-over-year.
- LENSAR, INC. net cash provided by (used in) investing activities for the quarter ending 2025-09-30 was $4.00M.
- LENSAR, INC. net cash provided by (used in) investing activities for fiscal 2025 was $1.28M.
- LENSAR, INC. net cash provided by (used in) investing activities for fiscal 2024 was -$2.16M.
- LENSAR, INC. net cash provided by (used in) investing activities for fiscal 2023 was -$4.16M.
- LENSAR, INC. net cash provided by (used in) investing activities for fiscal 2022 was -$115.00K.
| Period end | Net Cash Provided by (Used in) Investing Activities 3 month | Net Cash Provided by (Used in) Investing Activities 6 month | Net Cash Provided by (Used in) Investing Activities 9 month | Net Cash Provided by (Used in) Investing Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | $965.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $4.96M 10-Q · filed 2026-08-13 | $9.21M derived: sum of 3 quarters · filed 2026-08-13 | $13.21M derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | $4.00M 10-Q · filed 2026-05-08 | $8.24M derived: sum of 2 quarters · filed 2026-05-08 | $12.24M derived: sum of 3 quarters · filed 2026-05-08 | $4.75M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | $4.25M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $8.24M derived: sum of 2 quarters · filed 2026-03-31 | $753.00K derived: sum of 3 quarters · filed 2026-08-13 | $1.28M 10-K · filed 2026-03-31 |
| 2025-09-30 | $4.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$3.49M derived: sum of 2 quarters · filed 2026-08-13 | -$2.96M 10-Q · filed 2025-11-06 | -$969.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | -$7.49M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | -$6.96M 10-Q · filed 2026-08-13 | -$4.97M derived: sum of 3 quarters · filed 2026-08-13 | -$5.87M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | $531.00K 10-Q · filed 2026-05-08 | $2.52M derived: sum of 2 quarters · filed 2026-05-08 | $1.62M derived: sum of 3 quarters · filed 2026-05-08 | -$404.00K derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | $1.99M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $1.09M derived: sum of 2 quarters · filed 2026-03-31 | -$935.00K derived: sum of 3 quarters · filed 2026-03-31 | -$2.16M 10-K · filed 2026-03-31 |
| 2024-09-30 | -$905.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$2.93M derived: sum of 2 quarters · filed 2025-11-06 | -$4.15M 10-Q · filed 2025-11-06 | -$8.12M derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-06-30 | -$2.02M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | -$3.25M 10-Q · filed 2025-08-07 | -$7.21M derived: sum of 3 quarters · filed 2025-08-07 | -$7.21M derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-03-31 | -$1.23M 10-Q · filed 2025-05-08 | -$5.19M derived: sum of 2 quarters · filed 2025-05-08 | -$5.19M derived: sum of 3 quarters · filed 2025-05-08 | -$5.37M derived: sum of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | -$3.96M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | -$3.97M derived: sum of 2 quarters · filed 2025-02-27 | -$4.15M derived: sum of 3 quarters · filed 2025-02-27 | -$4.16M 10-K · filed 2025-02-27 |
| 2023-09-30 | -$2.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | -$183.00K derived: sum of 2 quarters · filed 2024-11-07 | -$191.00K 10-Q · filed 2024-11-07 | -$248.00K derived: sum of 4 quarters · filed 2024-11-07 |
| 2023-06-30 | -$181.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | -$189.00K 10-Q · filed 2024-08-08 | -$246.00K derived: sum of 3 quarters · filed 2024-08-08 | -$248.00K derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | -$8.00K 10-Q · filed 2024-05-09 | -$65.00K derived: sum of 2 quarters · filed 2024-05-09 | -$67.00K derived: sum of 3 quarters · filed 2024-05-09 | -$77.00K derived: sum of 4 quarters · filed 2024-05-09 |
| 2022-12-31 | -$57.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-04 | -$59.00K derived: sum of 2 quarters · filed 2024-03-04 | -$69.00K derived: sum of 3 quarters · filed 2024-03-04 | -$115.00K 10-K · filed 2024-03-04 |
| 2022-09-30 | -$2.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | -$12.00K derived: sum of 2 quarters · filed 2023-11-09 | -$58.00K 10-Q · filed 2023-11-09 | -$214.00K derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | -$10.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | -$56.00K 10-Q · filed 2023-08-09 | -$212.00K derived: sum of 3 quarters · filed 2023-08-09 | -$276.00K derived: sum of 4 quarters · filed 2023-08-09 |
| 2022-03-31 | -$46.00K 10-Q · filed 2023-05-15 | -$202.00K derived: sum of 2 quarters · filed 2023-05-15 | -$266.00K derived: sum of 3 quarters · filed 2023-05-15 | -$286.00K derived: sum of 4 quarters · filed 2023-05-15 |
| 2021-12-31 | -$156.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | -$220.00K derived: sum of 2 quarters · filed 2023-03-16 | -$240.00K derived: sum of 3 quarters · filed 2023-03-16 | -$354.00K 10-K · filed 2023-03-16 |
| 2021-09-30 | -$64.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | -$84.00K derived: sum of 2 quarters · filed 2022-11-09 | -$198.00K 10-Q · filed 2022-11-09 | -$303.00K derived: sum of 4 quarters · filed 2022-11-09 |
| 2021-06-30 | -$20.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | -$134.00K 10-Q · filed 2022-08-08 | -$239.00K derived: sum of 3 quarters · filed 2022-08-08 | -$225.00K derived: sum of 4 quarters · filed 2022-08-08 |
| 2021-03-31 | -$114.00K 10-Q · filed 2022-05-09 | -$219.00K derived: sum of 2 quarters · filed 2022-05-09 | -$205.00K derived: sum of 3 quarters · filed 2022-05-09 | -$347.00K derived: sum of 4 quarters · filed 2022-05-09 |
| 2020-12-31 | -$105.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-03 | -$91.00K derived: sum of 2 quarters · filed 2022-03-03 | -$233.00K derived: sum of 3 quarters · filed 2022-03-03 | -$326.00K 10-K · filed 2022-03-03 |
| 2020-09-30 | $14.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08 | -$128.00K derived: sum of 2 quarters · filed 2021-11-08 | -$221.00K 10-Q · filed 2021-11-08 | -$292.00K derived: sum of 4 quarters · filed 2021-11-08 |
| 2020-06-30 | -$142.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-06 | -$235.00K 10-Q · filed 2021-08-06 | -$306.00K derived: sum of 3 quarters · filed 2021-08-06 | |
| 2020-03-31 | -$93.00K 10-Q · filed 2021-05-06 | -$164.00K derived: sum of 2 quarters · filed 2021-05-06 | ||
| 2019-12-31 | -$71.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-12 | -$2.09M 10-K · filed 2021-03-12 | ||
| 2019-09-30 | -$2.02M 10-Q · filed 2020-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Apyx Medical Corp (APYX) | United States | $0.120B | -21.85 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B |